![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sepracor Inc. (MM) | NASDAQ:SEPR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 22.98 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
(Amendment No. 3)
SOLICITATION/RECOMMENDATION
STATEMENT UNDER
SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
Sepracor Inc.
(Name of Subject Company)
Sepracor Inc.
(Name of Persons Filing Statement)
Common Stock, par value $0.10 per
share, and the
Associated Preferred Stock Purchase Rights
(Title of Class of Securities)
817315104
(CUSIP Number of Class of Securities)
Andrew I. Koven, Esq.
Executive Vice President, General
Counsel and Corporate Secretary
Sepracor Inc.
84
Waterford Drive
Marlborough, Massachusetts
01752
(508) 481-6700
(Name, address and
telephone numbers of person authorized to receive notices
and communications on behalf of the persons
filing statement)
Copies to:
William J. Grant, Jr. |
|
Hal J. Leibowitz |
Russell L. Leaf |
|
Susan W. Murley |
Adam M. Turteltaub |
|
Lia Der Marderosian |
Willkie Farr & Gallagher LLP |
|
Wilmer Cutler Pickering Hale and Dorr LLP |
787 Seventh Avenue |
|
60 State Street |
New York, New York 10019 |
|
Boston, MA 02109 |
Telephone: (212) 728-8000 |
|
Telephone: (617) 526-6000 |
Facsimile: (212) 728-8111 |
|
Facsimile: (671) 526-5000 |
o Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
This Amendment No. 3 (this Amendment No. 3 ) amends and supplements Items 8 and 9 in the Solicitation/Recommendation Statement on Schedule 14D-9 initially filed with the U.S. Securities and Exchange Commission on September 15, 2009, by Sepracor Inc., a Delaware corporation (the Company ), as amended or supplemented from time to time (the Schedule 14D-9 ). The Schedule 14D-9 relates to the cash tender offer by Aptiom, Inc. ( Merger Sub ), a Delaware corporation and an indirect wholly owned subsidiary of Dainippon Sumitomo Pharma Co., Ltd., a company formed under the laws of Japan, to purchase all of the Companys outstanding Shares at a price of $23.00 per Share, payable net to the seller in cash without interest thereon, less any applicable withholding taxes, upon the terms and subject to the conditions set forth in Merger Subs Offer to Purchase dated September 15, 2009, and in the related Letter of Transmittal, as each may be amended or supplemented from time to time.
Except as otherwise set forth below, the information set forth in the Schedule 14D-9 remains unchanged and is incorporated herein by reference as relevant to items in this Amendment No. 3. Capitalized terms used but not otherwise defined herein have the meanings ascribed to such terms in the Schedule 14D-9.
Item 8. Additional Information to be Furnished.
Item 8 of the Schedule 14D-9 is hereby amended and supplemented by adding the following new paragraphs to the end of Item 8:
(m) Expiration of the Initial Offering Period; Subsequent Offering Period
Parent and the Company announced on October 14, 2009 that the initial offering period had expired and that Merger Sub has accepted for payment all of the Shares validly tendered and not properly withdrawn pursuant to the Offer prior to the expiration of the initial offering period. According to Computershare Trust Company, N.A., the depositary for the Offer, as of 12:00 midnight, New York City time, at the end of the day on Tuesday, October 13, 2009, a total of approximately 86,913,744 shares of Company common stock were validly tendered and not properly withdrawn in the initial offering period (excluding Shares tendered through notices of guaranteed delivery), representing approximately 78.2% of all outstanding shares of Company common stock.
2
Parent also announced that Merger Sub has commenced a subsequent offering period for all of the remaining untendered shares of Company common stock that will expire at 5:00 p.m., New York City time, on October 19, 2009, unless extended.
Item 9. Exhibits.
Item 9 of the Schedule 14D-9 is hereby amended and supplemented by adding the following exhibit thereto:
Exhibit No. |
|
|
|
|
|
(a)(13) |
|
Press Release issued by the Company and Parent dated October 14, 2009.* |
* Filed herewith.
3
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
|
SEPRACOR INC. |
|
|
|
|
|
By: |
/s/ Andrew I. Koven |
|
|
|
|
Name: |
Andrew I. Koven |
|
Title: |
Executive Vice President, General Counsel and Corporate Secretary |
|
|
|
Dated: October 14, 2009 |
|
|
Index to Exhibits
Exhibit No. |
|
|
|
|
|
(a)(13) |
|
Press Release issued by the Company and Parent dated October 14, 2009.* |
* Filed herewith.
1 Year Sepracor Inc. (MM) Chart |
1 Month Sepracor Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions